Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 567

1.

Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.

Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, Agabio R, Colombo G, Gessa GL, Gasbarrini G.

Alcohol Alcohol. 2002 Sep-Oct;37(5):504-8.

PMID:
12217947
2.

Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.

Addolorato G, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G.

Alcohol Clin Exp Res. 2000 Jan;24(1):67-71.

PMID:
10656195
3.

Baclofen for alcohol dependence: a preliminary open-label study.

Flannery BA, Garbutt JC, Cody MW, Renn W, Grace K, Osborne M, Crosby K, Morreale M, Trivette A.

Alcohol Clin Exp Res. 2004 Oct;28(10):1517-23.

PMID:
15597084
4.

A pilot double-blind treatment trial of memantine for alcohol dependence.

Evans SM, Levin FR, Brooks DJ, Garawi F.

Alcohol Clin Exp Res. 2007 May;31(5):775-82. Epub 2007 Mar 22.

PMID:
17378918
5.

[Effect of angiotensin II synthesis inhibition on alcohol consumption].

Guivernau M, Pallavicini J.

Rev Med Chil. 2008 Aug;136(8):968-75. doi: /S0034-98872008000800002. Epub 2008 Oct 7. Spanish.

6.

Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.

Addolorato G, Leggio L, Ferrulli A, Cardone S, Bedogni G, Caputo F, Gasbarrini G, Landolfi R; Baclofen Study Group.

Alcohol Alcohol. 2011 May-Jun;46(3):312-7. doi: 10.1093/alcalc/agr017. Epub 2011 Mar 17.

PMID:
21414953
7.

Ondansetron reduces the craving of biologically predisposed alcoholics.

Johnson BA, Roache JD, Ait-Daoud N, Zanca NA, Velazquez M.

Psychopharmacology (Berl). 2002 Apr;160(4):408-13. Epub 2002 Feb 12.

PMID:
11919668
9.

Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.

Karhuvaara S, Simojoki K, Virta A, Rosberg M, Löyttyniemi E, Nurminen T, Kallio A, Mäkelä R.

Alcohol Clin Exp Res. 2007 Jul;31(7):1179-87. Epub 2007 Apr 19.

PMID:
17451401
10.

Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial.

Marra D, Warot D, Berlin I, Hispard E, Notides C, Tilikete S, Payan C, Lépine JP, Dally S, Aubin HJ.

Alcohol Clin Exp Res. 2002 Oct;26(10):1545-52.

PMID:
12394288
11.

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.

Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B.

Alcohol Alcohol. 2000 Nov-Dec;35(6):587-93.

PMID:
11093966
12.

Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study.

Leggio L, Ferrulli A, Cardone S, Miceli A, Kenna GA, Gasbarrini G, Swift RM, Addolorato G.

Alcohol. 2008 Aug;42(5):375-81. doi: 10.1016/j.alcohol.2008.03.128. Epub 2008 May 16.

PMID:
18486430
13.

Ritanserin, a central 5-HT2 antagonist, in heavy social drinkers: desire to drink, alcohol intake and related effects.

Naranjo CA, Poulos CX, Lanctôt KL, Bremner KE, Kwok M, Umana M.

Addiction. 1995 Jul;90(7):893-905.

PMID:
7663312
14.

Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial.

Furieri FA, Nakamura-Palacios EM.

J Clin Psychiatry. 2007 Nov;68(11):1691-700.

PMID:
18052562
15.

Fluoxetine attenuates alcohol intake and desire to drink.

Naranjo CA, Poulos CX, Bremner KE, Lanctot KL.

Int Clin Psychopharmacol. 1994 Sep;9(3):163-72.

PMID:
7814825
16.

Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers.

Drobes DJ, Anton RF, Thomas SE, Voronin K.

Alcohol Clin Exp Res. 2004 Sep;28(9):1362-70.

PMID:
15365307
17.

Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial.

Garbutt JC, Kampov-Polevoy AB, Gallop R, Kalka-Juhl L, Flannery BA.

Alcohol Clin Exp Res. 2010 Nov;34(11):1849-57. doi: 10.1111/j.1530-0277.2010.01273.x.

18.

Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report.

Agabio R, Marras P, Addolorato G, Carpiniello B, Gessa GL.

J Clin Psychopharmacol. 2007 Jun;27(3):319-20. No abstract available.

PMID:
17502794
19.

Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.

Gann H, Feige B, Cloot O, Van Wasen H, Zinzgraf D, Hohagen F, Riemann D.

Pharmacopsychiatry. 2004 Sep;37(5):228-35.

PMID:
15359376
20.

Relationship between the hypothalamic-pituitary-thyroid axis and alcohol craving in alcohol-dependent patients: a longitudinal study.

Leggio L, Ferrulli A, Cardone S, Malandrino N, Mirijello A, D'Angelo C, Vonghia L, Miceli A, Capristo E, Kenna GA, Gasbarrini G, Swift RM, Addolorato G.

Alcohol Clin Exp Res. 2008 Dec;32(12):2047-53. doi: 10.1111/j.1530-0277.2008.00792.x. Epub 2008 Sep 25.

PMID:
18828809

Supplemental Content

Support Center